logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5598.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5598.produseast1
Showing 1 - 20 of 86 Items
Showing 1 - 20 of 86 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Closing the hepatitis B birth-dose gap in Cameroon: Global evidence and policy imperatives

Akem TE
2025-10-06 • Human Vaccines and Immunotherapeutics
2025-10-06 • Human Vaccines and Immunotherapeutics

Hepatitis B virus infects an estimated 254 million people worldwide and caused 1.1 million deaths in 2022. In the WHO African Region, about 65 million people live with chronic HBV (HB...

Technical Report
|
Evidence Brief

Hepatitis C campaign in Rohingya refugee camps

MSF
2025-09-01
2025-09-01
Journal Article
|
Research

Diagnostic performance and kinetics of hepatitis E viral RNA and IgM antibody test positivity in a genotype 1 outbreak in South Sudan

Koyuncu A, Nesbitt R, Alvarez C, Asilaza KV, Wamala J,  et al.
2025-08-14 • Journal of Infectious Diseases
2025-08-14 • Journal of Infectious Diseases

BACKGROUND

Diagnostics are essential for understanding hepatitis E epidemiology, but the field performanc...

Conference Material
|
Abstract

Bending the curve of hepatitis C virus infection in Machar Colony: a mass screen-and-treat intervention in a slum settlement in Karachi, Pakistan

Aslam MK, de Glanville WA, Wailly Y, Miazek M, Hamid S,  et al.
2025-05-22 • MSF Scientific Days International 2025
2025-05-22 • MSF Scientific Days International 2025
Conference Material
|
Slide Presentation

Bending the curve of hepatitis C virus infection in Machar Colony: a mass screen-and-treat intervention in a slum settlement in Karachi, Pakistan

Aslam MK, de Glanville WA, Wailly Y, Miazek M, Hamid S,  et al.
2025-05-22 • MSF Scientific Days International 2025
2025-05-22 • MSF Scientific Days International 2025
Journal Article
|
Research

Prevalence of hepatitis C virus seropositivity and active infection in a Rohingya refugee population in Cox's Bazar camps, Bangladesh: a cross-sectional study

Schramm B, Ashakin KA, Firuz W, Hadiuzzaman M, Ben-Farhat J,  et al.
2025-04-01 • Lancet Gastroenterology and Hepatology
2025-04-01 • Lancet Gastroenterology and Hepatology
Journal Article
|
Research

High confidence and demand for hepatitis E vaccine during an outbreak in Bentiu, South Sudan: A qualitative study

Koyuncu A, Asilaza KV, Rumunu J, Wamala J, Gitahi P,  et al.
2025-03-06 • PLOS Global Public Health
2025-03-06 • PLOS Global Public Health

In 2021 in response to an outbreak of hepatitis E in Bentiu internally displaced persons camp the South Sudanese Ministry of Health with support from Médecins Sans Frontières implemen...

Journal Article
|
Research

The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case–control and bias indicator study

Nesbitt RC, Kinya Asilaza V, Alvarez C, Gitahi P, Nkemenang P,  et al.
2025-01-08 • Lancet Infectious Diseases
2025-01-08 • Lancet Infectious Diseases

BACKGROUND

Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalen...

Journal Article
|
Research

Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan

Nesbitt RC, Azman AS, Asilaza VK, Edwards JK, Gitahi P,  et al.
2024-11-01 • Lancet Global Health
2024-11-01 • Lancet Global Health
Journal Article
|
Research

Usability and acceptability of self-testing for hepatitis C virus exposure in a high-prevalence urban informal settlement in Karachi, Pakistan

Mazzilli S, Aslam MK, Akhtar J, Miazek M, Wailly Y,  et al.
2024-09-27 • BMC Infectious Diseases
2024-09-27 • BMC Infectious Diseases

BACKGROUND

Hepatitis C virus (HCV) antibody self-testing (HCVST) may help expand screening access and support HCV elimination efforts. Despite potential benefit...

Conference Material
|
Video

A concern for large-scale treatment access: High prevalence of active HCV infection among forcibly displaced Myanmar nationals residing in camps, Cox’s Bazar, Bangladesh

Schramm B
2024-07-01 • Epicentre Scientific Day 2024
2024-07-01 • Epicentre Scientific Day 2024
Conference Material
|
Poster

Prevalence of active hepatitis C virus (HCV) infection and associated factors among forcibly displaced Myanmar nationals residing in camps, Cox’s Bazar, Bangladesh

Ashakin KA, Hadiuzzaman M, Firuz W, Rahman A, Ben-Farhat J,  et al.
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
Conference Material
|
Abstract

Hepatitis E outbreak response in Fangak County, South Sudan: coverage and acceptance of a vaccination campaign targeting women of reproductive age

Aumuller J
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
BACKGROUND
In September 2023, the South Sudan Ministry of Health declared an outbreak of hepatitis E virus in Fangak County, Jonglei State. From April to November 2023, MSF identifie...
Conference Material
|
Abstract

First mass reactive vaccination campaign against Hepatitis E: main results of observational studies

Gignoux EM
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024

BACKGROUND

Hepatitis E was first identified in the 1990s, but major epidemics date back to the 1950s. There is no specific treatment, and it can be fatal especially for pregnant...

Conference Material
|
Video

First mass reactive vaccination campaign against Hepatitis E: main results of observational studies

Gignoux EM
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
Conference Material
|
Abstract

A concern for large-scale treatment access: High prevalence of active HCV infection among forcibly displaced Myanmar Nationals residing in camps, Cox’s Bazar, Bangladesh

Schramm B, Hossain FN
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024

BACKGROUND

Hepatitis C virus (HCV) is a major cause of liver diseases globally. Transmission is primarily bloodborne through unsafe injections or healthcare practices. Effective...

Conference Material
|
Video

Safety of hepatitis E vaccine in pregnancy emulating a target trial following a mass reactive vaccination campaign in South Sudan

Gignoux EM
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|
Slide Presentation

Safety of hepatitis E vaccine in pregnancy: emulating a target trial following a mass reactive vaccination campaign in South Sudan

Nesbitt R, Azman AS, Asilaza VK, Edwards JK, Nkemenang P,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|
Abstract

Safety of hepatitis E vaccine in pregnancy: emulating a target trial following a mass reactive vaccination campaign in South Sudan

Nesbitt R, Azman AS, Asilaza VK, Edwards JK, Nkemenang P,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024

INTRODUCTION

Hepatitis E causes high mortality among pregnant women, with case fatality risks over 30% and adverse fetal outcomes. There is an evidence gap on the safety of the ...

Conference Material
|
Poster

Evaluation of a simplified model of care for chronic hepatitis C infection in Rohingya population in Ukhiya, Cox’s Bazar, Bangladesh

Firuz W, Ashakin KA, Schramm B, Camelique O, Duka M,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024